| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | synapse organization | SPARC FRMPD4 KIF1A CLSTN2 DBN1 PLXNB2 ZNF804A AFDN BSN CACNA1S PCLO RTN4 PCDHB10 PCDHB4 PCDHB3 LRRC4B SPG11 GRIN2B SLITRK5 AGRN NOS1AP | 1.32e-05 | 685 | 218 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | SPARC FRMPD4 KIF1A CLSTN2 DBN1 PLXNB2 ZNF804A SVEP1 PARD6B AFDN PLEC BSN CACNA1S ANK2 PCLO RTN4 PCDHB10 PCDHB4 PCDHB3 LRRC4B SPG11 GRIN2B TJP1 SLITRK5 AGRN NOS1AP | 1.38e-05 | 974 | 218 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | KIF1A FRS2 DBN1 PLXNB2 AFDN DAGLA NOTCH2 RPGRIP1 TACC2 IGF2BP1 VCAN | 3.99e-05 | 233 | 218 | 11 | GO:0061351 |
| GeneOntologyCellularComponent | costamere | 7.66e-05 | 22 | 221 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | postsynaptic specialization | FRMPD4 MAP1A CLSTN2 DBN1 BMPR2 AFDN BSN DAGLA ANK2 PCLO RTN4 ZDHHC5 LRRC4B GRIN2B USP8 SLITRK5 | 9.59e-05 | 503 | 221 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | FRMPD4 MAP1A CLSTN2 DBN1 BMPR2 AFDN BSN DAGLA ANK2 PCLO RTN4 LRRC4B GRIN2B USP8 SLITRK5 | 9.73e-05 | 451 | 221 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | FRMPD4 MAP1A CLSTN2 DBN1 BMPR2 AFDN BSN DAGLA ANK2 PCLO RTN4 LRRC4B GRIN2B USP8 SLITRK5 | 1.80e-04 | 477 | 221 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | postsynapse | FRMPD4 MAP1A KIF1A KIF1B CLSTN2 DBN1 ZNF804A BMPR2 AFDN BSN DAGLA CACNA1S ANK2 PCLO RTN4 ZDHHC5 LRRC4B GRIN2B USP8 IGF2BP1 ARRB1 ARRB2 SLITRK5 NOS1AP | 2.08e-04 | 1018 | 221 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | FRMPD4 MAP1A KIF1A KIF1B CLSTN2 DBN1 ZNF804A BMPR2 KCNN3 ASTN2 AFDN CACNA1G PLEC BSN DAGLA CACNA1S PCLO RTN4 ZDHHC5 LMTK2 SPG11 GRIN2B USP8 IGF2BP1 ARRB1 ARRB2 SNX18 | 2.54e-04 | 1228 | 221 | 27 | GO:0036477 |
| GeneOntologyCellularComponent | dendritic spine | FRMPD4 DBN1 ZNF804A DAGLA CACNA1S GRIN2B USP8 IGF2BP1 ARRB1 ARRB2 | 2.66e-04 | 242 | 221 | 10 | GO:0043197 |
| GeneOntologyCellularComponent | neuron spine | FRMPD4 DBN1 ZNF804A DAGLA CACNA1S GRIN2B USP8 IGF2BP1 ARRB1 ARRB2 | 3.13e-04 | 247 | 221 | 10 | GO:0044309 |
| GeneOntologyCellularComponent | dendrite | FRMPD4 MAP1A KIF1A KIF1B CLSTN2 DBN1 ZNF804A BMPR2 CACNA1G PLEC BSN DAGLA CACNA1S PCLO ZDHHC5 SPG11 GRIN2B USP8 IGF2BP1 ARRB1 ARRB2 | 3.20e-04 | 858 | 221 | 21 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FRMPD4 MAP1A KIF1A KIF1B CLSTN2 DBN1 ZNF804A BMPR2 CACNA1G PLEC BSN DAGLA CACNA1S PCLO ZDHHC5 SPG11 GRIN2B USP8 IGF2BP1 ARRB1 ARRB2 | 3.30e-04 | 860 | 221 | 21 | GO:0097447 |
| GeneOntologyCellularComponent | anchoring collagen complex | 3.31e-04 | 3 | 221 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | FRMPD4 MAP1A CLSTN2 DBN1 BMPR2 AFDN BSN DAGLA ANK2 PCLO RTN4 LRRC4B GRIN2B USP8 SLITRK5 | 4.76e-04 | 523 | 221 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | nuclear body | MAGEA10 SETX ERCC6 BARD1 ZNF202 CMYA5 ZNF638 ASCC2 AFDN FOXO4 CASP8AP2 SMC4 UBOX5 RFWD3 ARRB1 ACIN1 ELF4 SNAPC3 CDC5L TOPORS SON | 6.24e-04 | 903 | 221 | 21 | GO:0016604 |
| GeneOntologyCellularComponent | dendritic microtubule | 6.58e-04 | 4 | 221 | 2 | GO:1901588 | |
| GeneOntologyCellularComponent | supramolecular fiber | MAP1A KIF1A KIF1B MDM1 MYOZ2 DBN1 CMYA5 ZNF804A FBN2 AHNAK BYSL PLEC CACNA1S COL11A2 CHMP6 ANK2 GTSE1 DNAJB4 GRIN2B MAP10 MFAP5 DNAH17 CCDC181 SPAG17 NOS1AP | 7.35e-04 | 1179 | 221 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MAP1A KIF1A KIF1B MDM1 MYOZ2 DBN1 CMYA5 ZNF804A FBN2 AHNAK BYSL PLEC CACNA1S COL11A2 CHMP6 ANK2 GTSE1 DNAJB4 GRIN2B MAP10 MFAP5 DNAH17 CCDC181 SPAG17 NOS1AP | 8.09e-04 | 1187 | 221 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | axon | SETX MAP1A KIF1A KIF1B DBN1 ZNF804A ITPR2 BMPR2 AFDN PLEC BSN DAGLA PCLO LMTK2 LRRC4B SPG11 GRIN2B IGF2BP1 SNX18 AGRN | 1.29e-03 | 891 | 221 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | cilium | CDK20 RABEP2 MAP1A MDM1 FSCB ALMS1 SCNN1A CPLANE1 NOTCH2 RPGRIP1 TBC1D30 PCDHB15 PRAMEF12 VCAN DNAH17 CFAP57 CCDC181 SPAG17 TOPORS PHLPP2 | 1.42e-03 | 898 | 221 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.43e-03 | 157 | 221 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 1.62e-03 | 6 | 221 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | I band | 1.97e-03 | 166 | 221 | 7 | GO:0031674 | |
| Domain | Cadherin_C | 1.27e-04 | 42 | 219 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.27e-04 | 42 | 219 | 5 | PF16492 | |
| Domain | Znf_piccolo | 1.37e-04 | 2 | 219 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.37e-04 | 2 | 219 | 2 | PF05715 | |
| Domain | CADHERIN_1 | 3.74e-04 | 113 | 219 | 7 | PS00232 | |
| Domain | Cadherin | 3.74e-04 | 113 | 219 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 3.94e-04 | 114 | 219 | 7 | PS50268 | |
| Domain | - | 3.94e-04 | 114 | 219 | 7 | 2.60.40.60 | |
| Domain | CA | 4.16e-04 | 115 | 219 | 7 | SM00112 | |
| Domain | Cadherin-like | 4.38e-04 | 116 | 219 | 7 | IPR015919 | |
| Domain | Cadherin | 4.86e-04 | 118 | 219 | 7 | IPR002126 | |
| Domain | Laminin_G | 5.85e-04 | 58 | 219 | 5 | IPR001791 | |
| Domain | - | 7.96e-04 | 16 | 219 | 3 | 1.10.506.10 | |
| Domain | Kinesin-like_KIF1-typ | 8.09e-04 | 4 | 219 | 2 | IPR022140 | |
| Domain | Arrestin_N | 8.09e-04 | 4 | 219 | 2 | IPR014753 | |
| Domain | KIF1B | 8.09e-04 | 4 | 219 | 2 | PF12423 | |
| Domain | Arrestin_CS | 8.09e-04 | 4 | 219 | 2 | IPR017864 | |
| Domain | ARRESTINS | 8.09e-04 | 4 | 219 | 2 | PS00295 | |
| Domain | Arrestin | 8.09e-04 | 4 | 219 | 2 | IPR000698 | |
| Domain | - | 8.09e-04 | 4 | 219 | 2 | 2.60.40.840 | |
| Domain | - | 8.86e-04 | 95 | 219 | 6 | 2.60.120.200 | |
| Domain | Cadherin_2 | 9.88e-04 | 65 | 219 | 5 | PF08266 | |
| Domain | Cadherin_N | 9.88e-04 | 65 | 219 | 5 | IPR013164 | |
| Domain | RasGAP_dom | 1.14e-03 | 18 | 219 | 3 | IPR001936 | |
| Domain | ConA-like_dom | 1.15e-03 | 219 | 219 | 9 | IPR013320 | |
| Domain | Defensin_propep | 1.34e-03 | 5 | 219 | 2 | PF00879 | |
| Domain | Alpha-defensin | 1.34e-03 | 5 | 219 | 2 | IPR006081 | |
| Domain | TMEM132D_N | 1.34e-03 | 5 | 219 | 2 | PF15705 | |
| Domain | TMEM132D_C | 1.34e-03 | 5 | 219 | 2 | PF15706 | |
| Domain | TMEM132_M | 1.34e-03 | 5 | 219 | 2 | IPR031437 | |
| Domain | TMEM132_C | 1.34e-03 | 5 | 219 | 2 | IPR031436 | |
| Domain | TMEM132_N | 1.34e-03 | 5 | 219 | 2 | IPR031435 | |
| Domain | Alpha-defensin_pro | 1.34e-03 | 5 | 219 | 2 | IPR016327 | |
| Domain | DEFENSIN | 1.34e-03 | 5 | 219 | 2 | PS00269 | |
| Domain | Defensin_propep | 1.34e-03 | 5 | 219 | 2 | IPR002366 | |
| Domain | TMEM132 | 1.34e-03 | 5 | 219 | 2 | IPR026307 | |
| Domain | TMEM132 | 1.34e-03 | 5 | 219 | 2 | PF16070 | |
| Domain | Defensin_1 | 1.34e-03 | 5 | 219 | 2 | PF00323 | |
| Domain | PP2C | 1.34e-03 | 19 | 219 | 3 | PF00481 | |
| Domain | PP2Cc | 1.56e-03 | 20 | 219 | 3 | SM00332 | |
| Domain | - | 1.56e-03 | 20 | 219 | 3 | 3.60.40.10 | |
| Domain | PPM-type_phosphatase_dom | 1.56e-03 | 20 | 219 | 3 | IPR001932 | |
| Domain | PPM_2 | 1.56e-03 | 20 | 219 | 3 | PS51746 | |
| Domain | Cadherin_CS | 1.80e-03 | 109 | 219 | 6 | IPR020894 | |
| Domain | - | 1.83e-03 | 148 | 219 | 7 | 2.60.40.150 | |
| Domain | Kinesin_assoc | 1.99e-03 | 6 | 219 | 2 | PF16183 | |
| Domain | zf-RING_5 | 1.99e-03 | 6 | 219 | 2 | PF14634 | |
| Domain | Kinesin-like | 1.99e-03 | 6 | 219 | 2 | IPR022164 | |
| Domain | - | 1.99e-03 | 6 | 219 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 1.99e-03 | 6 | 219 | 2 | IPR027295 | |
| Domain | Kinesin_assoc | 1.99e-03 | 6 | 219 | 2 | IPR032405 | |
| Domain | DUF3694 | 1.99e-03 | 6 | 219 | 2 | PF12473 | |
| Pubmed | MAP1A PSMD2 DBN1 C2CD2L HSPA12A BMPR2 PLEC BSN ANK2 PCLO RTN4 ZDHHC5 GRIN2B DNAJC5 TRAPPC14 PPP6R2 | 1.60e-09 | 347 | 229 | 16 | 17114649 | |
| Pubmed | FRMPD4 ACACB MAP1A ACTR3C PSMD2 DBN1 C2CD2L HSPA12A AFDN PLEC BSN RGPD2 ANK2 PCLO RTN4 LMTK2 LRRC4B TACC2 GRIN2B MECR TJP1 TRIM28 FAM169A SLITRK5 PPP6R2 CNOT1 NOS1AP | 1.05e-08 | 1139 | 229 | 27 | 36417873 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX AFTPH KIF1B ARHGEF17 KIAA0753 BMPR2 ALMS1 AHNAK AFDN FOXO4 PLEC ABTB2 NOTCH2 CRTC3 MAP7D3 PARP8 GTSE1 LMTK2 MAGI3 USP8 TJP1 TRAPPC14 NOS1AP | 1.62e-08 | 861 | 229 | 23 | 36931259 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | AFTPH ACACB ZBTB48 MAP1A ZNF804A ZKSCAN5 TASOR2 PEX5 PLEC BSN CACNA1S CRTC3 GTSE1 ARRB2 RASAL3 SON | 3.28e-08 | 430 | 229 | 16 | 35044719 |
| Pubmed | ACACB KIF1B DBN1 KIAA0753 ALMS1 GFOD1 AFDN NOTCH2 CRTC3 PARP8 USP8 TJP1 SNX18 TRAPPC14 PPP6R2 CNOT1 | 5.42e-08 | 446 | 229 | 16 | 24255178 | |
| Pubmed | SETX ACACB ARL11 KIF1B FRS2 TASOR2 FAT1 DDX50 AHNAK ZNF638 PEX5 AFDN NOTCH2 MAP7D3 ZDHHC5 IPO4 TRIM33 IGF2BP1 TJP1 SLITRK5 TJAP1 | 5.78e-08 | 777 | 229 | 21 | 35844135 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH ACACB KIF1B FBN2 ALMS1 NFKBIE PEX5 AFDN MINDY4 PLEC CPLANE1 MAP7D3 GTSE1 ZNF507 MAGI3 FHIP2A TJP1 SNX18 PPP6R2 CNOT1 AGRN | 2.71e-07 | 853 | 229 | 21 | 28718761 |
| Pubmed | SETX ERCC6 AFTPH ZNF638 AFDN DDX24 BAG6 SGTA GTSE1 TACC2 IPO4 IGF2BP1 GTF3C2 TRIM28 ACIN1 SON | 2.75e-07 | 503 | 229 | 16 | 16964243 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AFTPH ACACB MAP1A DBN1 ALMS1 DDX50 AHNAK FEN1 ZNF638 ANK2 MAP7D3 RTN4 TACC2 USP8 IGF2BP1 TJP1 TRIM28 FAM169A ACIN1 CDC5L PPP6R2 SON | 2.94e-07 | 934 | 229 | 22 | 33916271 |
| Pubmed | 3.37e-07 | 68 | 229 | 7 | 22779921 | ||
| Pubmed | ZBTB48 MAP1A KIF1B MYOZ2 FRS2 FOXN3 ITPR2 FAT1 C17orf75 GFOD1 AHNAK FEN1 ZNF638 ASCC2 FOXO4 PLEC CCDC33 CASP8AP2 CRTC3 COL12A1 CHMP6 REV3L IGF2BP1 GTF3C2 VCAN POLQ | 4.91e-07 | 1293 | 229 | 26 | 15342556 | |
| Pubmed | SETX ZBTB48 SPP1 TASOR2 ALMS1 AHNAK ZNF638 BAG6 SMC4 TRIM33 GTF3C2 TRIM28 ACIN1 CDC5L CNOT1 | 6.12e-07 | 469 | 229 | 15 | 27634302 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ENDOD1 POU6F2 KIF1A ACTR3C KIF1B BARD1 FOXN3 PFKFB4 TASOR2 BMPR2 SCNN1A ZNF638 ASTN2 DAGLA NOTCH2 RASA1 SGTA KSR2 MAGI3 WASHC3 TEP1 ARRB1 ARRB2 TJP1 TJAP1 PBX2 ZNF839 CNOT1 | 6.56e-07 | 1489 | 229 | 28 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AFTPH KIF1B DBN1 PRDM2 ZBTB40 ZNF638 AFDN PLEC DDX24 BAG6 NOTCH2 SGTA GTSE1 ZNF507 TRIM28 ACIN1 TJAP1 TOPORS SON | 1.07e-06 | 774 | 229 | 19 | 15302935 |
| Pubmed | ACACB CWC27 PSMD2 DBN1 TASOR2 ABCB4 DDX50 AHNAK PLEC BSN RPGRIP1 RGPD2 ANK2 PCDHGB5 PARP8 PCLO SMC4 MAGI3 SPG11 USP8 ARRB1 TJP1 FAM169A ACIN1 DNAJC5 POLQ SPAG17 | 1.15e-06 | 1442 | 229 | 27 | 35575683 | |
| Pubmed | 1.27e-06 | 160 | 229 | 9 | 31678930 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 PCNX3 PLXNB2 ITPR2 C2CD2L FAT1 AHNAK PLEC BCL2L13 ABTB2 NOTCH2 CHMP6 GTSE1 KSR2 ZDHHC5 LMTK2 FRMD8 REV3L TEP1 TRIM28 HMGXB3 ZNF839 AGRN | 1.31e-06 | 1105 | 229 | 23 | 35748872 |
| Pubmed | SPARC PLXNB2 FBN2 COL14A1 ADAMTSL1 COL11A2 COL12A1 MFAP5 AGRN | 2.66e-06 | 175 | 229 | 9 | 28071719 | |
| Pubmed | SETX PRDM2 KIAA0753 DDX50 ZBTB40 ZNF638 PLEC CPLANE1 FAM234B ZNF507 LMTK2 WASHC3 PRAMEF12 TACC2 UBOX5 VCAN DZIP3 ACIN1 HMGXB3 CNOT1 AGRN LRRC71 | 3.38e-06 | 1084 | 229 | 22 | 11544199 | |
| Pubmed | ACACB DBN1 ARHGEF17 DDX50 AHNAK PLEC DDX24 TEX15 IGF2BP1 CDC5L | 3.89e-06 | 234 | 229 | 10 | 36243803 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 4.00e-06 | 184 | 229 | 9 | 32908313 | |
| Pubmed | RABEP2 ERCC2 KIF1A BARD1 PSMD2 AHNAK ASCC2 PLEC BAG6 LMTK2 TBL3 RNF123 TOPORS AGRN | 4.34e-06 | 481 | 229 | 14 | 28190767 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PSMD2 PLXNB2 ITPR2 DDX50 AHNAK ZNF638 PEX5 AFDN PLEC BAG6 CHMP6 GTSE1 SMC4 TBL3 IGF2BP1 TJP1 TRIM28 ACIN1 CDC5L CNOT1 SON | 4.87e-06 | 1024 | 229 | 21 | 24711643 |
| Pubmed | ERCC2 ERCC6 MAP1A BCL7B CLSTN2 ZKSCAN5 C2CD2L FAT1 FBN2 ALMS1 GFOD1 PEX5 DDX24 NOTCH2 REV3L TEP1 TRIM33 RASAL3 TRIM28 TOPORS NOS1AP SON | 5.36e-06 | 1116 | 229 | 22 | 31753913 | |
| Pubmed | Afadin orients cell division to position the tubule lumen in developing renal tubules. | 5.55e-06 | 6 | 229 | 3 | 28860115 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ERCC2 AFTPH NFKBIE BYSL PEX5 ABTB2 CRTC3 EPS8L2 GTSE1 FHIP2A RFWD3 TRIM33 IGF2BP1 ARRB2 TJP1 SNX18 TJAP1 SNAPC3 PPP6R2 CNOT1 NOS1AP | 5.98e-06 | 1038 | 229 | 21 | 26673895 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX DBN1 TASOR2 DDX50 AHNAK FEN1 BYSL ZNF638 AFDN DDX24 MAP7D3 GTSE1 TBL3 TRIM33 IGF2BP1 TJP1 TRIM28 ACIN1 CDC5L SON | 5.99e-06 | 954 | 229 | 20 | 36373674 |
| Pubmed | AFTPH FRS2 PLXNB2 KIAA0753 ITPR2 HSPA12A BYSL ASCC2 COL14A1 DDX24 BAG6 NOTCH2 CASP8AP2 ANK2 SGTA RTN4 ZDHHC5 DNAJB4 SPG11 IPO4 TBL3 GTF3C2 DNAJC5 CDC5L PPP6R2 NOS1AP | 6.27e-06 | 1487 | 229 | 26 | 33957083 | |
| Pubmed | 6.97e-06 | 197 | 229 | 9 | 36604605 | ||
| Pubmed | KIF1A PSMD2 TASOR2 AHNAK BYSL ZNF638 AFDN PLEC DDX24 SMC4 IPO4 TBL3 TJP1 ACIN1 CNOT1 SON | 7.95e-06 | 653 | 229 | 16 | 22586326 | |
| Pubmed | 8.17e-06 | 20 | 229 | 4 | 11322959 | ||
| Pubmed | mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex. | 8.17e-06 | 20 | 229 | 4 | 23416452 | |
| Pubmed | 8.17e-06 | 20 | 229 | 4 | 20846217 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX KIF1A FRS2 ARHGEF17 TMEM132B PRDM2 ITPR2 AHNAK TBC1D30 PCLO SMC4 MAGI3 REV3L RNF123 CFAP57 PBX2 CNOT1 | 8.90e-06 | 736 | 229 | 17 | 29676528 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SETX MAP1A PSMD2 DBN1 DDX50 AHNAK RTN4 GTSE1 TACC2 TRIM33 TJP1 TRIM28 CDC5L | 9.00e-06 | 444 | 229 | 13 | 34795231 |
| Pubmed | 9.67e-06 | 7 | 229 | 3 | 21382013 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KIF1B TNFRSF14 PSMD2 TNFRSF10D CMYA5 AFDN DDX24 BAG6 CHMP6 RTN4 SMC4 IPO4 USP8 IGF2BP1 RNF123 ARRB1 ARRB2 TRIM28 ACIN1 CDC5L POLQ CNOT1 SON | 1.52e-05 | 1284 | 229 | 23 | 17353931 |
| Pubmed | Comparative analysis of apoptosis and inflammation genes of mice and humans. | 1.53e-05 | 80 | 229 | 6 | 12819136 | |
| Pubmed | Association of ASIP/mPAR-3 with adherens junctions of mouse neuroepithelial cells. | 1.54e-05 | 8 | 229 | 3 | 12203721 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | RABEP2 ACACB PSMD2 DBN1 TASOR2 FEN1 ZNF638 DDX24 NOTCH2 MAP7D3 SMC4 IPO4 TBL3 TRIM28 SON | 1.92e-05 | 624 | 229 | 15 | 33729478 |
| Pubmed | ERCC2 PCNX3 PLXNB2 TASOR2 FAT1 FBN2 FEN1 COL14A1 BCL2L13 CCDC33 CRTC3 ANK2 RTN4 GTSE1 DNAJB4 TACC2 TRIM33 TJP1 VCAN SNX18 ELF4 AGRN | 1.99e-05 | 1215 | 229 | 22 | 15146197 | |
| Pubmed | 2.10e-05 | 284 | 229 | 10 | 29459677 | ||
| Pubmed | 2.30e-05 | 9 | 229 | 3 | 21144999 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.31e-05 | 86 | 229 | 6 | 28327460 | |
| Pubmed | 2.36e-05 | 128 | 229 | 7 | 23858473 | ||
| Pubmed | RABEP2 DBN1 TMEM132B PEX5 AFDN BSN RGPD2 ANK2 KSR2 GRIN2B IPO4 TJP1 TRIM28 DZIP3 TJAP1 CDC5L PPP6R2 CNOT1 AGRN | 2.38e-05 | 963 | 229 | 19 | 28671696 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FRS2 DBN1 BMPR2 AHNAK NFKBIE AFDN PLEC NOTCH2 EPS8L2 RTN4 ZDHHC5 MAGI3 USP8 TJP1 | 2.62e-05 | 565 | 229 | 14 | 25468996 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIF1A PSMD2 DBN1 CMYA5 PRDM2 DDX50 FEN1 BYSL AFDN BSN DDX24 BAG6 PCLO RTN4 SMC4 IPO4 PPAT TBL3 IGF2BP1 GTF3C2 TRIM28 ACIN1 CDC5L CNOT1 | 2.66e-05 | 1425 | 229 | 24 | 30948266 |
| Pubmed | ENDOD1 ZKSCAN5 KIAA0753 ALMS1 ASTN2 TBC1D30 ZDHHC5 MAGI3 DNAH17 FAM169A SLITRK5 CDC5L PPP6R2 | 2.69e-05 | 493 | 229 | 13 | 15368895 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | ERCC6 DBN1 DDX24 NOTCH2 RTN4 IGF2BP1 DZIP3 ACIN1 CDC5L CNOT1 SON | 2.86e-05 | 358 | 229 | 11 | 32460013 |
| Pubmed | 2.88e-05 | 54 | 229 | 5 | 24823311 | ||
| Pubmed | KIF1B MYOZ2 CMYA5 GSDME ALMS1 ZBTB40 COL14A1 PLEC NOTCH2 COL12A1 ANK2 SNAPC3 SON | 2.93e-05 | 497 | 229 | 13 | 23414517 | |
| Pubmed | FRS2 PARD6B ZNF638 BAG6 CHMP6 SGTA GTSE1 USP8 IGF2BP1 POLQ SON | 2.94e-05 | 359 | 229 | 11 | 35559673 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ENDOD1 MAP1A PCNX3 PSMD2 ITPR2 A2ML1 FEN1 ZNF638 CPLANE1 RTN4 KSR2 TBL3 SNX18 TREX2 MAP3K13 CNOT1 | 3.19e-05 | 732 | 229 | 16 | 34732716 |
| Pubmed | AFTPH ACACB DBN1 PLXNB2 ITPR2 AHNAK BEND7 BYSL PLEC SGTA ZDHHC5 TJP1 ELF4 | 3.31e-05 | 503 | 229 | 13 | 36217030 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.32e-05 | 135 | 229 | 7 | 28675934 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ERCC6 PSMD2 DBN1 TASOR2 ITPR2 DDX50 AHNAK FEN1 BYSL ZNF638 ASCC2 PLEC DDX24 MAP7D3 SMC4 IPO4 TBL3 TJP1 TRIM28 ACIN1 CDC5L TOPORS | 3.32e-05 | 1257 | 229 | 22 | 36526897 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX ERCC6 PSMD2 DDX50 AHNAK A2ML1 FEN1 BYSL ZNF638 AFDN PLEC DDX24 BAG6 SMC4 IPO4 TBL3 ARRB2 GTF3C2 TRIM28 ACIN1 CDC5L AGRN SON | 3.43e-05 | 1353 | 229 | 23 | 29467282 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 3.75e-05 | 57 | 229 | 5 | 32633719 | |
| Pubmed | 3.83e-05 | 94 | 229 | 6 | 32062451 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ACACB FEN1 ZNF638 PLEC RGPD2 GTSE1 TBL3 GTF3C2 ACIN1 ELF4 CDC5L | 3.86e-05 | 370 | 229 | 11 | 22922362 |
| Pubmed | ERCC6 SVEP1 FBN2 ASCC2 AFDN PLEC BAG6 NOTCH2 ZNF510 RNF123 ARRB2 CCDC181 TOPORS SON | 4.26e-05 | 591 | 229 | 14 | 15231748 | |
| Pubmed | Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. | 4.32e-05 | 2 | 229 | 2 | 12871849 | |
| Pubmed | Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. | 4.32e-05 | 2 | 229 | 2 | 18703513 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 15609093 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 4.32e-05 | 2 | 229 | 2 | 23403927 | |
| Pubmed | Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function. | 4.32e-05 | 2 | 229 | 2 | 28973019 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 3339096 | ||
| Pubmed | Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. | 4.32e-05 | 2 | 229 | 2 | 17426148 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 34344831 | ||
| Pubmed | ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation. | 4.32e-05 | 2 | 229 | 2 | 36215165 | |
| Pubmed | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. | 4.32e-05 | 2 | 229 | 2 | 17618287 | |
| Pubmed | Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. | 4.32e-05 | 2 | 229 | 2 | 21152079 | |
| Pubmed | Human Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas. | 4.32e-05 | 2 | 229 | 2 | 18957723 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 4.32e-05 | 2 | 229 | 2 | 26793095 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 34450275 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 9668034 | ||
| Pubmed | Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice. | 4.32e-05 | 2 | 229 | 2 | 31622341 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 16181421 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20332206 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 7539720 | ||
| Pubmed | Salivary levels of HNP 1-3 are related to oral ulcer activity in Behçet's disease. | 4.32e-05 | 2 | 229 | 2 | 22861387 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 12582207 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 26927499 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 32838755 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 4.32e-05 | 2 | 229 | 2 | 21935939 | |
| Pubmed | Defensins: antimicrobial and cytotoxic peptides of mammalian cells. | 4.32e-05 | 2 | 229 | 2 | 8476558 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 26649138 | ||
| Pubmed | Deficiency of β-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases. | 4.32e-05 | 2 | 229 | 2 | 30541881 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 25134464 | ||
| Pubmed | Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. | 4.32e-05 | 2 | 229 | 2 | 20589830 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21143350 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 28257821 | ||
| Pubmed | β-Arrestin2 mediates the initiation and progression of myeloid leukemia. | 4.32e-05 | 2 | 229 | 2 | 22773819 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 32919020 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 17418896 | ||
| Pubmed | β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer. | 4.32e-05 | 2 | 229 | 2 | 30787175 | |
| Pubmed | Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. | 4.32e-05 | 2 | 229 | 2 | 8080882 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 17960519 | ||
| Pubmed | Unique Roles of β-Arrestin in GPCR Trafficking Revealed by Photoinducible Dimerizers. | 4.32e-05 | 2 | 229 | 2 | 29330504 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | BCL7B SPDYE13 SPDYE15 SPDYE21 SPDYE5 SPDYE14 CASTOR2 SPDYE18 | 7.39e-05 | 271 | 230 | 8 | chr7q11 |
| Cytoband | 7q11.23 | 1.34e-04 | 97 | 230 | 5 | 7q11.23 | |
| Cytoband | 5q31 | 2.96e-04 | 115 | 230 | 5 | 5q31 | |
| GeneFamily | Clustered protocadherins | 2.07e-04 | 64 | 153 | 5 | 20 | |
| GeneFamily | PDZ domain containing | 3.15e-04 | 152 | 153 | 7 | 1220 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 3.70e-04 | 17 | 153 | 3 | 701 | |
| GeneFamily | Classical arrestins | 4.22e-04 | 4 | 153 | 2 | 1312 | |
| GeneFamily | Ring finger proteins | 5.66e-04 | 275 | 153 | 9 | 58 | |
| GeneFamily | ADAMTS like | 1.45e-03 | 7 | 153 | 2 | 947 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 1.45e-03 | 7 | 153 | 2 | 1268 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.85e-03 | 29 | 153 | 3 | 782 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 3.06e-03 | 10 | 153 | 2 | 830 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.46e-03 | 36 | 153 | 3 | 823 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | ENDOD1 SETX KIF1B BARD1 C17orf75 COL14A1 CPLANE1 REV3L KLHL11 IGF2BP1 VCAN DZIP3 PBX2 AGRN | 8.66e-06 | 330 | 218 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | ENDOD1 SETX C17orf75 COL14A1 CPLANE1 SMC4 IGF2BP1 VCAN DZIP3 PBX2 AGRN | 2.84e-05 | 231 | 218 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | ENDOD1 SETX C17orf75 CLCA1 COL14A1 CPLANE1 ADAMTSL1 TBC1D30 SMC4 MFAP5 IGF2BP1 VCAN DZIP3 PBX2 AGRN | 3.22e-05 | 421 | 218 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | POU6F2 SETX ERCC6 ALMS1 ZNF638 CASP8AP2 RASA1 PCLO RTN4 SMC4 MAGI3 TJP1 FAM169A ACIN1 POLQ TOPORS CNOT1 | 3.80e-05 | 532 | 218 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ACTR3C CMYA5 PARD6B FAT1 SCNN1A ASTN2 AFDN ABTB2 RNF152 PCLO TACC2 SLC22A5 MAP3K13 | 2.26e-11 | 193 | 226 | 13 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ACTR3C PARD6B FAT1 SCNN1A AFDN ABTB2 EPS8L2 ANK2 KSR2 MAGI3 TACC2 FAM169A NOS1AP | 2.75e-11 | 196 | 226 | 13 | c7136b1c83bcf907eec3b02b151fa061298b6672 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ACTR3C SPP1 PARD6B FAT1 SCNN1A ASTN2 ABTB2 EPS8L2 PCLO MAP3K13 | 6.16e-08 | 194 | 226 | 10 | 5eaaa81f4b2535f983c424aaef00077089526a5c |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CLSTN2 DBN1 SVEP1 HSPA12A COL14A1 ADAMTSL1 COL12A1 ANK2 MFAP5 VCAN | 6.46e-08 | 195 | 226 | 10 | f54bc4454270ff06e85596f98199372b50d0179f |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ENDOD1 HSPA12A AHNAK SCNN1A EPS8L2 TACC2 TJP1 CEACAM20 PHLPP2 | 2.05e-07 | 168 | 226 | 9 | 03896466698a79f7f1ad862cb7e05585260e2a5a |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | FRMPD4 ACTR3C SCNN1A ASTN2 ADAMTSL1 RNF152 MAGI3 ADAMTSL3 FAM169A | 4.04e-07 | 182 | 226 | 9 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PARD6B SCNN1A EPS8L2 ADAMTSL1 LMTK2 MAGI3 TACC2 ARRB1 TMEM132D | 4.43e-07 | 184 | 226 | 9 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 4.85e-07 | 186 | 226 | 9 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PARD6B AFDN EPS8L2 ADAMTSL1 COL12A1 LMTK2 MAGI3 TMEM132D AGRN | 5.31e-07 | 188 | 226 | 9 | eea652bab161f19148a883e7e3fe2523b36b3cea |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-07 | 194 | 226 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-07 | 195 | 226 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 7.52e-07 | 196 | 226 | 9 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-07 | 196 | 226 | 9 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-07 | 196 | 226 | 9 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-07 | 146 | 226 | 8 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CLSTN2 SVEP1 COL14A1 ABTB2 ADAMTSL1 ANK2 ADAMTSL3 MFAP5 VCAN | 8.90e-07 | 200 | 226 | 9 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CLSTN2 SVEP1 COL14A1 ADAMTSL1 COL12A1 ANK2 ADAMTSL3 MFAP5 VCAN | 8.90e-07 | 200 | 226 | 9 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 182 | 226 | 8 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 182 | 226 | 8 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 183 | 226 | 8 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 183 | 226 | 8 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-06 | 184 | 226 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-06 | 184 | 226 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 4.69e-06 | 184 | 226 | 8 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-06 | 184 | 226 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.07e-06 | 186 | 226 | 8 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 5.49e-06 | 188 | 226 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-06 | 190 | 226 | 8 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-06 | 190 | 226 | 8 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.93e-06 | 190 | 226 | 8 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-06 | 190 | 226 | 8 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.41e-06 | 192 | 226 | 8 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.41e-06 | 192 | 226 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.41e-06 | 192 | 226 | 8 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.41e-06 | 192 | 226 | 8 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-06 | 192 | 226 | 8 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.41e-06 | 192 | 226 | 8 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 6.41e-06 | 192 | 226 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 6.65e-06 | 193 | 226 | 8 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.65e-06 | 193 | 226 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.65e-06 | 193 | 226 | 8 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 193 | 226 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-06 | 193 | 226 | 8 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 6.65e-06 | 193 | 226 | 8 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.91e-06 | 194 | 226 | 8 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.91e-06 | 194 | 226 | 8 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-06 | 194 | 226 | 8 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.91e-06 | 194 | 226 | 8 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 195 | 226 | 8 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 195 | 226 | 8 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.45e-06 | 196 | 226 | 8 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 196 | 226 | 8 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.45e-06 | 196 | 226 | 8 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.32e-06 | 199 | 226 | 8 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.32e-06 | 199 | 226 | 8 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.32e-06 | 199 | 226 | 8 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-06 | 199 | 226 | 8 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.32e-06 | 199 | 226 | 8 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.63e-06 | 200 | 226 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.63e-06 | 200 | 226 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.63e-06 | 200 | 226 | 8 | f0818821c495022569aef2c1886d9f2446dc027e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.63e-06 | 200 | 226 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 200 | 226 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.63e-06 | 200 | 226 | 8 | f9baef67dde62f1c161a9408a78f635ea70ea9d3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 200 | 226 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.63e-06 | 200 | 226 | 8 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.63e-06 | 200 | 226 | 8 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 200 | 226 | 8 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.63e-06 | 200 | 226 | 8 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 1.72e-05 | 159 | 226 | 7 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 167 | 226 | 7 | 6c2dade24a88af04b2c90a7e4f8dd7ccea9e94d1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 171 | 226 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 2.85e-05 | 172 | 226 | 7 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.18e-05 | 175 | 226 | 7 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 176 | 226 | 7 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-05 | 177 | 226 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.42e-05 | 177 | 226 | 7 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-05 | 178 | 226 | 7 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-05 | 178 | 226 | 7 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-05 | 178 | 226 | 7 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 179 | 226 | 7 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-05 | 180 | 226 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 3.94e-05 | 181 | 226 | 7 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-05 | 182 | 226 | 7 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.08e-05 | 182 | 226 | 7 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-05 | 182 | 226 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-05 | 183 | 226 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-05 | 183 | 226 | 7 | 6ca7c2d7c56e0f1b9038ba677b4c1c3dfd63bfce | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.22e-05 | 183 | 226 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-05 | 183 | 226 | 7 | 18040d0653286071df959513c63d94b555a5d00a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.37e-05 | 184 | 226 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-05 | 126 | 226 | 6 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.48e-05 | 126 | 226 | 6 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.50e-05 | 77 | 226 | 5 | dbbefd2dfa4c345172cb5a995952e3682fbadf92 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 185 | 226 | 7 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.53e-05 | 185 | 226 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 185 | 226 | 7 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-05 | 186 | 226 | 7 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.68e-05 | 127 | 226 | 6 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 187 | 226 | 7 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ACACB ZBTB48 KIF1A ARHGEF17 HSPA12A DAGLA CHMP6 ERN2 UBOX5 MZF1 FAM169A TRAPPC14 | 6.63e-07 | 198 | 224 | 12 | 3198_DN |
| Drug | BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A | ACACB C17orf75 SGTA SMC4 TRIM33 MZF1 DZIP3 ELF4 SNAPC3 TOPORS ZNF839 | 3.72e-06 | 194 | 224 | 11 | 6876_DN |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A | ZBTB48 ITPR2 ZBTB40 TBC1D30 TEP1 ERN2 UBOX5 MZF1 TRAPPC14 POLQ ZNF839 | 4.11e-06 | 196 | 224 | 11 | 3633_DN |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | SETX ASTN2 ALAD PLEC SGTA ZNF510 ERN2 RNF123 MECR ZNF839 PPP6R2 | 4.11e-06 | 196 | 224 | 11 | 4956_DN |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | ERCC2 ACACB CPLANE1 FAM234B ZNF510 REV3L UBOX5 VCAN TJAP1 ZNF839 CNOT1 | 4.53e-06 | 198 | 224 | 11 | 6668_DN |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; HL60; HT_HG-U133A | ENDOD1 KIF1A TRAIP KIAA0753 SYCP2 NOTCH2 MAP7D3 ZNF510 TEP1 ARRB1 VCAN | 4.53e-06 | 198 | 224 | 11 | 2349_UP |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | RABEP2 SETX KIF1A TRAIP ITPR2 PLEC NOTCH2 ANK2 SMC4 ERN2 TRAPPC14 | 4.75e-06 | 199 | 224 | 11 | 2402_DN |
| Drug | tamibarotene | SPP1 MDM1 TNFRSF14 PRDM2 ITPR2 FAT1 FBN2 ALMS1 PIK3CG AHNAK FOXO4 DAGLA COL11A2 ICAM3 SMC4 REV3L PPAT TRIM33 SON | 7.62e-06 | 596 | 224 | 19 | ctd:C061133 |
| Drug | FS B | 8.45e-06 | 14 | 224 | 4 | CID000004290 | |
| Drug | AC1Q6PCP | SPP1 MYOZ2 ABCB4 GSDME SCNN1A COL14A1 CACNA1G PLEC COL11A2 COL12A1 SLC22A5 | 1.86e-05 | 230 | 224 | 11 | CID000005267 |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | SYCP2 ALMS1 AHNAK ZBTB40 NOTCH2 PCLO ZNF510 LPIN2 FAM169A DZIP3 | 2.07e-05 | 191 | 224 | 10 | 4168_DN |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | ERCC2 PHF20 PARD6B BMPR2 CLCA1 TBC1D30 TEP1 MZF1 ELF4 TRAPPC14 | 2.36e-05 | 194 | 224 | 10 | 4134_DN |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | ZBTB48 ARHGEF17 PRDM2 CLCA1 ASTN2 COL14A1 DAGLA UBOX5 TJAP1 TRAPPC14 | 2.36e-05 | 194 | 224 | 10 | 6242_UP |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A | ERCC2 PHF20 ACACB TNFRSF10D ABCB4 ALMS1 ALAD GTSE1 SMC4 TJAP1 | 2.47e-05 | 195 | 224 | 10 | 2478_DN |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.47e-05 | 195 | 224 | 10 | 5269_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | KIF1A SVEP1 CLCA1 CCDC33 ANK2 PCLO PRAMEF12 TJP1 SLC22A5 DZIP3 | 2.47e-05 | 195 | 224 | 10 | 2426_UP |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | ENDOD1 PHF20 SPP1 TNFRSF10D ABCB4 ZBTB40 DNAJB4 ARRB1 VCAN AGRN | 2.47e-05 | 195 | 224 | 10 | 2973_DN |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | TRAIP CLSTN2 ITPR2 C2CD2L PARD6B HSPA12A DNAJB4 UBOX5 HMGXB3 TRAPPC14 | 2.58e-05 | 196 | 224 | 10 | 1512_DN |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A | MDM1 TNFRSF14 PRDM2 BMPR2 ALMS1 AHNAK FOXO4 PCLO ARRB1 ZNF839 | 2.58e-05 | 196 | 224 | 10 | 2935_DN |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | ACACB PFKFB4 DBN1 ITPR2 ZBTB40 WASHC3 UBOX5 TRIM33 ELF4 TRAPPC14 | 2.70e-05 | 197 | 224 | 10 | 371_DN |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; MCF7; HT_HG-U133A | ZBTB48 ZNF202 ZKSCAN5 PEX5 AFDN DAGLA NOTCH2 CASP10 ELF4 CDC5L | 2.70e-05 | 197 | 224 | 10 | 7553_DN |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | ZBTB48 ZKSCAN5 ASTN2 ALAD PLEC TBC1D30 RNF123 FAM169A TRAPPC14 AGRN | 2.70e-05 | 197 | 224 | 10 | 5227_DN |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | ZBTB48 ZNF202 CLSTN2 PLEC NOTCH2 PCLO SMC4 UBOX5 ARRB1 DZIP3 | 2.82e-05 | 198 | 224 | 10 | 5013_DN |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | RABEP2 MDM1 C17orf75 ASTN2 TBC1D30 RNF123 MZF1 DZIP3 ELF4 PPP6R2 | 2.82e-05 | 198 | 224 | 10 | 6260_DN |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | ZBTB48 TRAIP C2CD2L BMPR2 ZBTB40 ASTN2 PLEC GTSE1 ELF4 PPP6R2 | 2.82e-05 | 198 | 224 | 10 | 4979_DN |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | ACACB ZNF202 ZNF804A ZKSCAN5 PLEC PCLO UBOX5 MFAP5 DNAH17 NOS1AP | 2.82e-05 | 198 | 224 | 10 | 5266_DN |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | ERCC2 ZKSCAN5 PARD6B CLCA1 DAGLA CASP10 PRAMEF12 ZNF510 MFAP5 CCDC181 | 2.94e-05 | 199 | 224 | 10 | 7230_UP |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | MDM1 C2CD2L GFOD1 ASTN2 DNAJB4 ERN2 TRIM33 MZF1 DZIP3 TRAPPC14 | 2.94e-05 | 199 | 224 | 10 | 2754_DN |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | RABEP2 ERCC2 ACACB TRAIP ARHGEF17 PRDM2 COL14A1 FOXO4 CCDC33 VCAN | 2.94e-05 | 199 | 224 | 10 | 4957_UP |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; HL60; HT_HG-U133A | ZKSCAN5 C2CD2L CHMP6 TBC1D30 SMC4 CASP10 TBL3 VCAN SNAPC3 TRAPPC14 | 3.07e-05 | 200 | 224 | 10 | 1871_DN |
| Drug | AC1L1E3B | 7.00e-05 | 44 | 224 | 5 | CID000002622 | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.67e-05 | 180 | 224 | 9 | 7420_UP | |
| Drug | 1zd2 | 7.82e-05 | 45 | 224 | 5 | CID004149241 | |
| Drug | DBTC | 8.33e-05 | 73 | 224 | 6 | CID000101938 | |
| Drug | 2-methoxyethoxy)acetic acid | 9.64e-05 | 2 | 224 | 2 | CID000027642 | |
| Drug | 1,2,5,6-tetramethylnaphthalene | 9.64e-05 | 2 | 224 | 2 | CID006427081 | |
| Drug | 1,4,5-trimethylnaphthalene | 9.64e-05 | 2 | 224 | 2 | CID000016478 | |
| Drug | p-sulfobenzyl alcohol | 9.64e-05 | 2 | 224 | 2 | CID000441138 | |
| Drug | azotochelin | 9.64e-05 | 2 | 224 | 2 | CID000193592 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A | 1.07e-04 | 188 | 224 | 9 | 3046_UP | |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.16e-04 | 190 | 224 | 9 | 7209_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A | 1.25e-04 | 192 | 224 | 9 | 7392_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | MYOZ2 FRS2 ARHGEF17 COL14A1 MAP7D3 TBC1D30 CCDC181 TRAPPC14 PHLPP2 | 1.25e-04 | 192 | 224 | 9 | 4268_UP |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.25e-04 | 192 | 224 | 9 | 1332_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 1.30e-04 | 193 | 224 | 9 | 2930_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; PC3; HT_HG-U133A | 1.30e-04 | 193 | 224 | 9 | 6732_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.30e-04 | 193 | 224 | 9 | 3098_DN | |
| Drug | P G 0 | 1.34e-04 | 27 | 224 | 4 | CID000008134 | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.36e-04 | 194 | 224 | 9 | 4262_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.36e-04 | 194 | 224 | 9 | 4573_UP | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; HL60; HG-U133A | 1.36e-04 | 194 | 224 | 9 | 1610_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.41e-04 | 195 | 224 | 9 | 6180_DN | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | PPP1R14D FOXN3 DBN1 HSPA12A AFDN TBC1D30 MZF1 TRAPPC14 PPP6R2 | 1.41e-04 | 195 | 224 | 9 | 7403_UP |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | CDK20 C2CD2L HSPA12A PEX5 FAM234B RNF123 MZF1 FAM169A ZNF839 | 1.41e-04 | 195 | 224 | 9 | 3470_DN |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 1864_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 2922_DN | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 2263_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 3329_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 3217_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 1182_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | ALMS1 ASTN2 BCL2L13 MAP7D3 DNAJB4 MZF1 SNAPC3 TRAPPC14 PPP6R2 | 1.47e-04 | 196 | 224 | 9 | 7329_DN |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 3208_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 4359_DN | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; HL60; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 3085_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 2936_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 5795_DN | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; HL60; HG-U133A | 1.52e-04 | 197 | 224 | 9 | 1767_UP | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2644_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 3618_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 6776_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2124_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 3473_DN | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 7069_DN | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 6781_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 5479_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 1678_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2205_DN | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 6383_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2975_DN | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; PC3; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 4503_DN | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2484_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2131_DN | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; PC3; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 7289_UP | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 4785_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 5272_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | ERCC2 KIF1A TNFRSF10D DBN1 TBC1D30 ERN2 TBL3 RNF123 TRAPPC14 | 1.58e-04 | 198 | 224 | 9 | 6189_DN |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 6635_UP | |
| Drug | cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A | PPP1R14D CLSTN2 C2CD2L SCNN1A ZBTB40 CHMP6 MAP7D3 UBOX5 TBL3 | 1.58e-04 | 198 | 224 | 9 | 612_DN |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 1533_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 7390_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 4976_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 5102_UP | |
| Drug | 5194442; Down 200; 20uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 6599_DN | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 4021_DN | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 7513_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 2626_DN | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 6297_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A | ZKSCAN5 KIAA0753 C2CD2L AFDN FOXO4 FAM234B TBC1D30 DNAJB4 CASP10 | 1.58e-04 | 198 | 224 | 9 | 3107_DN |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 3311_DN | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; HL60; HG-U133A | 1.58e-04 | 198 | 224 | 9 | 1587_UP | |
| Disease | Colorectal Carcinoma | ERCC2 SPARC ERCC6 CLSTN2 ZNF804A ABCB4 FAT1 FBN2 FEN1 ANK2 TCN2 PARP8 RTN4 ADAMTSL3 TRIM28 ACIN1 SPAG17 | 2.06e-05 | 702 | 218 | 17 | C0009402 |
| Disease | PR interval | PCNX3 MYOZ2 BMPR2 FAT1 FBN2 BEND7 ZBTB40 ASTN2 CACNA1G PLEC LPIN2 TJAP1 CDC5L CNOT1 | 2.12e-05 | 495 | 218 | 14 | EFO_0004462 |
| Disease | transmembrane protein 132B measurement | 5.43e-05 | 2 | 218 | 2 | EFO_0802151 | |
| Disease | rotator cuff tear, shoulder impingement syndrome | 8.33e-05 | 12 | 218 | 3 | EFO_1001178, EFO_1001250 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 1.95e-04 | 39 | 218 | 4 | EFO_0008298 | |
| Disease | synucleinopathy (biomarker_via_orthology) | 3.23e-04 | 4 | 218 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | Cerebrooculofacioskeletal Syndrome 1 | 3.23e-04 | 4 | 218 | 2 | C0220722 | |
| Disease | progressive osseous heteroplasia (is_marker_for) | 5.35e-04 | 5 | 218 | 2 | DOID:0111535 (is_marker_for) | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 7.99e-04 | 6 | 218 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | calcinosis (is_marker_for) | 7.99e-04 | 6 | 218 | 2 | DOID:182 (is_marker_for) | |
| Disease | forced expiratory volume | POU6F2 TRAIP FRS2 ARHGEF17 PLXNB2 SVEP1 KIAA0753 AHNAK ZBTB40 ASCC2 ASTN2 ADAMTSL1 ADAMTSL3 CDC5L PPP6R2 | 8.33e-04 | 789 | 218 | 15 | EFO_0004314 |
| Disease | reticulocyte measurement | ENDOD1 MYOZ2 PSMD2 PLXNB2 ABCB4 BMPR2 FAT1 AHNAK ZBTB40 ASCC2 AFDN ALAD BSN KLHL11 DNAH17 SLC22A5 LPIN2 DNAJC5 | 8.83e-04 | 1053 | 218 | 18 | EFO_0010700 |
| Disease | Liver Cirrhosis | 1.02e-03 | 103 | 218 | 5 | C0023890 | |
| Disease | Colorectal Neoplasms | 1.11e-03 | 277 | 218 | 8 | C0009404 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 1.11e-03 | 7 | 218 | 2 | EFO_0020797 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 1.11e-03 | 7 | 218 | 2 | C2745997 | |
| Disease | Fibrosis, Liver | 1.12e-03 | 105 | 218 | 5 | C0239946 | |
| Disease | phosphatidylcholine 38:4 measurement | 1.14e-03 | 28 | 218 | 3 | EFO_0010386 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.38e-03 | 355 | 218 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.48e-03 | 8 | 218 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | C-reactive protein measurement | ERCC2 MAP1A TRAIP BCL7B HSPA12A BMPR2 AHNAK ZBTB40 KCNN3 BSN BCL2L13 DAGLA RPGRIP1 SPG11 IGF2BP1 GTF3C2 DNAH17 DNAJC5 CEACAM20 | 1.64e-03 | 1206 | 218 | 19 | EFO_0004458 |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 1.89e-03 | 9 | 218 | 2 | OBA_2045127 | |
| Disease | plexin-B2 measurement | 1.89e-03 | 9 | 218 | 2 | EFO_0021867 | |
| Disease | stomach cancer (is_implicated_in) | 2.01e-03 | 72 | 218 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | electrocardiography | CWC27 FOXN3 KCNN3 CACNA1G PLEC RPGRIP1 ZDHHC5 LRRC4B USP8 CNOT1 NOS1AP | 2.08e-03 | 530 | 218 | 11 | EFO_0004327 |
| Disease | glucagon-like peptide-1 measurement | 2.35e-03 | 10 | 218 | 2 | EFO_0008465 | |
| Disease | hepatocyte growth factor-like protein measurement | 2.77e-03 | 38 | 218 | 3 | EFO_0008154 | |
| Disease | rheumatoid arthritis, Crohn's disease | 2.77e-03 | 38 | 218 | 3 | EFO_0000384, EFO_0000685 | |
| Disease | Leukoencephalopathy | 2.86e-03 | 11 | 218 | 2 | C0270612 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 2.86e-03 | 11 | 218 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | microfibrillar-associated protein 2 measurement | 2.86e-03 | 11 | 218 | 2 | EFO_0801801 | |
| Disease | Basal cell carcinoma | 2.86e-03 | 11 | 218 | 2 | C0007117 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.86e-03 | 11 | 218 | 2 | EFO_0800332 | |
| Disease | small cell lung carcinoma | 2.96e-03 | 80 | 218 | 4 | EFO_0000702 | |
| Disease | unipolar depression, age at onset | 3.21e-03 | 40 | 218 | 3 | EFO_0003761, EFO_0004847 | |
| Disease | metabolite measurement, body weight gain | 3.42e-03 | 12 | 218 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | nervous system disease (implicated_via_orthology) | 3.42e-03 | 12 | 218 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.80e-03 | 139 | 218 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | breast carcinoma | PHF20 KIF1B FOXN3 PFKFB4 TASOR2 FBN2 ASTN2 COL14A1 NOTCH2 CCDC33 PARP8 LMTK2 MAGI3 TACC2 CASTOR2 SPAG17 | 3.91e-03 | 1019 | 218 | 16 | EFO_0000305 |
| Disease | psoriatic arthritis | 4.00e-03 | 87 | 218 | 4 | EFO_0003778 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 4.02e-03 | 13 | 218 | 2 | OBA_2045116 | |
| Disease | Malignant neoplasm of salivary gland | 4.49e-03 | 45 | 218 | 3 | C0220636 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 4.66e-03 | 14 | 218 | 2 | C1858991 | |
| Disease | trimethylamine-N-oxide measurement | 4.66e-03 | 14 | 218 | 2 | EFO_0010541 | |
| Disease | osteoarthritis, hip | 4.88e-03 | 92 | 218 | 4 | EFO_1000786 | |
| Disease | Disorder of eye | 5.06e-03 | 212 | 218 | 6 | C0015397 | |
| Disease | Salivary Gland Neoplasms | 5.08e-03 | 47 | 218 | 3 | C0036095 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.35e-03 | 15 | 218 | 2 | C0496930 | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 5.35e-03 | 15 | 218 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | Benign neoplasm of bladder | 5.35e-03 | 15 | 218 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.35e-03 | 15 | 218 | 2 | C0154091 | |
| Disease | complement factor H-related protein 4 measurement | 5.71e-03 | 49 | 218 | 3 | EFO_0600091 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.71e-03 | 49 | 218 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | mammographic density measurement | 6.04e-03 | 50 | 218 | 3 | EFO_0005941 | |
| Disease | focal segmental glomerulosclerosis | 6.09e-03 | 16 | 218 | 2 | EFO_0004236 | |
| Disease | Schizoaffective disorder-bipolar type | 6.09e-03 | 16 | 218 | 2 | EFO_0009965 | |
| Disease | Romano-Ward Syndrome | 6.09e-03 | 16 | 218 | 2 | C0035828 | |
| Disease | lymphocyte count | KIF1B PLXNB2 ITPR2 ALMS1 GFOD1 AHNAK ZNF638 PLEC NOTCH2 CACNA1S PCDHGB5 RTN4 ICAM3 ARRB2 RASAL3 DNAH17 SLC22A5 TSTD3 DZIP3 CDC5L | 6.22e-03 | 1464 | 218 | 20 | EFO_0004587 |
| Disease | Malignant neoplasm of breast | ERCC6 SPP1 BARD1 PFKFB4 DBN1 FSCB BMPR2 BEND7 ASTN2 NOTCH2 PGBD3 ANK2 PCDHB15 TACC2 MFAP5 MAP3K13 | 6.40e-03 | 1074 | 218 | 16 | C0006142 |
| Disease | Amyotrophic lateral sclerosis | 6.87e-03 | 17 | 218 | 2 | cv:C0002736 | |
| Disease | Uremia | 6.87e-03 | 17 | 218 | 2 | C0041948 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.10e-03 | 53 | 218 | 3 | C4707243 | |
| Disease | abdominal adipose tissue measurement | 7.10e-03 | 53 | 218 | 3 | EFO_0803316 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVALPEQTASEEETP | 401 | Q9UKV3 | |
| EEVVPALEPTETLLS | 396 | Q9BXK5 | |
| EPFIPTDLIENVVTV | 891 | P55196 | |
| PESIIELNLVPEEEN | 546 | P0CF97 | |
| EEVLPDVSPQALDLL | 251 | Q8IZL9 | |
| VLPAPQISDAELQEV | 296 | Q99459 | |
| TEVSLPLAEQIESPD | 276 | Q99728 | |
| LTQAIAETPENDIPE | 396 | Q6UX04 | |
| PSEDEVLGEPSQDIL | 991 | P13611 | |
| EEPLIASQSTEPEIG | 216 | Q8N5R6 | |
| SPESLSRDLEAPEVQ | 1081 | P46379 | |
| PSILVPDAEEEVTSL | 661 | Q6ULP2 | |
| ANPLDATQSEDVVLP | 36 | Q6UY09 | |
| QLPEEAVGLVTPETL | 391 | Q8WXI3 | |
| SVVVEEVPLQPGESL | 591 | Q9H1I8 | |
| PQVTEPDIDLDSENI | 1906 | Q7Z2Y8 | |
| VLIEDQFPSPVVVES | 61 | O60443 | |
| SESVSLELPVDIVPD | 926 | A8K2U0 | |
| TESELANEIPVPETL | 1886 | O00468 | |
| LPESNLTEEPLEVSA | 636 | Q8TCU4 | |
| IVAQISEPLAAADIP | 281 | A6NHX0 | |
| LTGPSVDVEVPDVEL | 2146 | Q09666 | |
| LDVTVPEAELNLETP | 4996 | Q09666 | |
| PEAELNLETPEISVG | 5001 | Q09666 | |
| SAITQEQIELPEVPS | 161 | Q96FZ7 | |
| VITENNDTVILDPPL | 51 | Q9H4D0 | |
| QEILEEPSLPSSEVA | 141 | Q9BQE9 | |
| ESILQPSIEEADILP | 761 | Q9UKL3 | |
| PENETPVDTNLIELD | 366 | P49407 | |
| AAPETDVPVDTNLIE | 361 | P32121 | |
| ATAPTLQEPSEIVEE | 186 | O75129 | |
| AELDQTTRDTLEPLP | 716 | Q86YV0 | |
| ELVTDFPTDLPATEV | 131 | P10451 | |
| LDELGNVPELPDTTE | 971 | P20936 | |
| QPDDEVVGILPLDSE | 81 | O95825 | |
| EEESLPSSVPELQQL | 406 | Q9H5N1 | |
| QPAPQLSVDLTEVEV | 71 | Q6PCD5 | |
| DTLLPSAIVPDIDEI | 1016 | Q14571 | |
| PQDFRPVSSIIDVDI | 136 | Q9BYG5 | |
| EDAESQVTADLPVPL | 451 | Q8N6L0 | |
| VEEAPATIAPLAIFE | 531 | O00763 | |
| DPSLVDEIFDQIPEL | 1106 | Q96PE2 | |
| LEVSVIENLPPVETE | 3511 | Q01484 | |
| LPESAAELTEVLNDP | 96 | Q969Q4 | |
| DSIEASAIVIQPPEN | 486 | P0DP91 | |
| PEDTAPETEILQISA | 1466 | Q14517 | |
| ALTPPQAEQEVDVLD | 1806 | Q04721 | |
| NDEDVLVTTEPIPVI | 71 | Q8N3A8 | |
| SIRSSQEEEPVDPQL | 101 | P40425 | |
| DEAVPQIIISAEELP | 196 | Q7Z418 | |
| EEVVSPANSIIPERL | 616 | Q9P2G4 | |
| VSETVDVPSPFDLLE | 11 | P78559 | |
| QVLPDSESLPRSEID | 121 | P43363 | |
| EDPVVDIVAATPVIN | 501 | Q5TCQ9 | |
| TVEETLADVQPLLPE | 416 | Q5H9T9 | |
| SAEIQLLAATEPPAD | 471 | Q5H9T9 | |
| QLLAAIEAPADETPA | 526 | Q5H9T9 | |
| PFPEQELESVTVEAL | 141 | Q86W26 | |
| LEDPSVFPAVIVEQV | 26 | Q99607 | |
| FVTDVPDDIQPITSL | 36 | P13716 | |
| LADDTVVPLAVENLP | 36 | Q9BZ67 | |
| LTAAEVVVPRDQTPD | 516 | Q9NZI8 | |
| SEVITPPEEISRIND | 1071 | O60333 | |
| LDVIQESESLIEFPP | 246 | Q96MR6 | |
| EREVGIPPEQSLETA | 81 | Q9C0K3 | |
| AQPLDDPEAEQLTVV | 501 | Q76MJ5 | |
| ETPQDLTEESLVLLP | 471 | O00221 | |
| PLLQIEVEPTSENEE | 606 | Q6VAB6 | |
| LADDTVVPLAVENLP | 36 | Q9BZ68 | |
| NLSPIEDASPTEELR | 1096 | Q9UPA5 | |
| PDDSLQILAPVEADV | 1231 | Q8N6G6 | |
| LVEPQIDDPNSNLEE | 96 | O94919 | |
| IEVSSPLPDVLNATE | 661 | Q12766 | |
| EDPQAEVSIDLLAEP | 216 | Q6H9L7 | |
| IPIVAQNSEEESPLS | 4351 | Q9Y6V0 | |
| VEQAASEPVVLPAEA | 531 | Q9H6A9 | |
| PLEGLQTILEEPENE | 616 | A0A0J9YXQ4 | |
| EVQLTVSPLPALSEE | 536 | O15031 | |
| PESEVLAEEIPASVS | 276 | P98177 | |
| PSRAEADVDIILSIP | 396 | Q9UGI6 | |
| LAAVRLDPTSIDPDV | 476 | P50542 | |
| TLAAPVVVLPDLDED | 256 | A2RU67 | |
| NVDISRPPEEALVTV | 451 | Q16877 | |
| PELQLVSAEPEVAAL | 246 | Q8N819 | |
| TVDPLPLREDSEDNI | 591 | Q8TC05 | |
| SLLPPLEEEQTDLQV | 306 | P13942 | |
| LEEEQTDLQVPPTAD | 311 | P13942 | |
| EEIVSLPPVESEAAQ | 246 | P12525 | |
| VEATEVVNPLLEPVE | 446 | Q8N4P6 | |
| IIIEPFDDRTPTIAN | 416 | P18074 | |
| QDISPDAVTVPVEIL | 856 | Q8IWU2 | |
| TLPSALEELEQEQEP | 561 | Q16643 | |
| SPENSEQLIIALEPE | 226 | O43301 | |
| ADSLQEVLPDITDRP | 661 | Q9Y5G0 | |
| EVLDTNDNPPELIVS | 336 | Q9UN67 | |
| IPENSPETEVALFRI | 356 | Q9Y5E8 | |
| SDEREATDTPIVIQP | 161 | Q9H3Z4 | |
| SLADTNLPSEVEPEL | 76 | Q9HAS0 | |
| IEELQNEEEELSPPL | 601 | Q86Y13 | |
| IESQEELEDFPLPTV | 106 | Q9H6S3 | |
| VDVSELAAEQLTAPP | 381 | Q9NYZ3 | |
| PNLVNDPATDETVLA | 46 | Q13361 | |
| LSRQPAVEEPAEVTA | 161 | P32942 | |
| LDVETDGLEANVPPV | 681 | P21439 | |
| VVDVNDNPPELIISS | 336 | Q9Y5E5 | |
| DDLLSQTPEIPIDIS | 886 | O43283 | |
| PEPLSVLLEQAEATL | 336 | O95522 | |
| DQLVDLEVPPLEDTT | 156 | Q5TID7 | |
| DETPNSIPADIVFII | 221 | Q9UDY4 | |
| QLFLEPEVLDPESVE | 281 | P39748 | |
| ASQVSDEILESLPPE | 581 | Q9NVR0 | |
| AAPEQIAADIPEVVV | 31 | P59665 | |
| AAPEQIAADIPEVVV | 31 | P59666 | |
| DPVAETAIRQLTEPS | 506 | O14523 | |
| TLEEIEVNASLPINP | 1691 | O43497 | |
| VTNLELPVREEPSND | 2601 | Q9H799 | |
| ELVSGEEVVEPPSNL | 326 | Q99715 | |
| ISPTPVDQLIAVVEE | 101 | Q9UFH2 | |
| IENIGETVDPVLDPL | 3486 | Q9UFH2 | |
| LDQVIPPIGDDEVTV | 1506 | Q13698 | |
| VSLNVDTPFPLEEEL | 571 | Q6UUV7 | |
| EINEVEVDPITTFPL | 576 | Q05707 | |
| QNDEIPVSLIDAVPT | 841 | Q14CM0 | |
| EPSSIEDRDPQILLE | 231 | Q8WU20 | |
| LRSVSPVQDLDDDTP | 81 | O00409 | |
| VSPRALELSDPVLDE | 1586 | O75417 | |
| LDPDQEQPDLTSIER | 451 | Q8N3K9 | |
| EQPDLTSIERAEPVS | 456 | Q8N3K9 | |
| ETDLSFIQPTIPSEE | 3036 | Q8N3K9 | |
| SETIPEQTLLPDEFV | 581 | Q5VWK5 | |
| PTPVCLQLTEEDLET | 651 | Q13873 | |
| EVDLVIQSSPPQDVE | 456 | Q9BQ39 | |
| LPQSSLIEVELEDVP | 586 | Q9Y6X4 | |
| VSLEALPEVSVEAAP | 396 | Q8IWC1 | |
| DALPDDTVIESEALP | 296 | Q9GZR7 | |
| VSPTEVDLTPELIFQ | 681 | Q9Y4D2 | |
| LAVNEDPVDSNLPVS | 181 | Q68CP4 | |
| IVLESPSSDPEVQLA | 271 | Q8N7W2 | |
| IQPSVSIEADALNPE | 406 | Q92851 | |
| EEALIQVPSDIPLQS | 146 | Q9BV79 | |
| TVDLTPEQLVIGTPD | 1011 | Q9NRM1 | |
| PQSVDPLDIETVEAI | 321 | Q5W0V3 | |
| IHEPDPTAVEQISLE | 2781 | P35556 | |
| TDIDAVEVPLPGNDV | 216 | O75052 | |
| AAPQQPTAEEEALIE | 36 | P37088 | |
| IVVPSTIFDPSELQD | 306 | O76082 | |
| LPVLLSTAQEADPEV | 901 | Q8TEX9 | |
| LQSAVPRDVEDVPIT | 421 | Q13895 | |
| EALEPDPLLTALESQ | 231 | O75170 | |
| PETDESLIDPNILSL | 1206 | Q12756 | |
| PTRTVEIINVEDELP | 611 | Q9NT99 | |
| TLQEVASQEVPPELA | 226 | Q13029 | |
| DPEEQPELSLTLTAL | 201 | Q9Y5E6 | |
| DQATPSEPEIDLEAL | 86 | Q9NXH3 | |
| TDDSIEASAIVIQPP | 16 | Q8N328 | |
| DPDLVVSDLVDTDPL | 341 | Q9BVI0 | |
| DSSPIEIIDEFPTLI | 861 | Q9NQC3 | |
| LPPDVSALATQAEIE | 951 | Q9NQC3 | |
| IQDVPEEFLDPITLE | 256 | O94941 | |
| AQEAEPPLTAVLVEE | 31 | Q9UPN9 | |
| QELDIVSPEDLATPI | 1246 | Q96KN7 | |
| VSQLPDDPEVLAVIA | 66 | Q8N8N0 | |
| TVEDSDLALPQTLPE | 46 | O43765 | |
| EVELLENPVDITLPS | 951 | Q14DG7 | |
| EVEEPGDLPATQLVT | 386 | Q14C87 | |
| SAPEQELLVQDATPV | 271 | Q9NXC2 | |
| VPLPDLVEVSSGEEN | 1331 | P0DJD1 | |
| ELATEEFLPVTPILE | 881 | Q13200 | |
| TAVPLEPLTDSLEEN | 676 | P78424 | |
| NVVIPDPDILTFDLD | 276 | Q5SGD2 | |
| VPTNEVIVSTSEDPL | 1451 | Q7Z333 | |
| DADPSVPDVVIDILQ | 351 | Q2KHM9 | |
| EDPEVIPENTDLVTL | 116 | Q92966 | |
| TASVPLPDERNDTLE | 921 | Q4LDE5 | |
| LEQVVATEEDLVPPS | 451 | Q6Q759 | |
| LEPAAETIPQTQEII | 316 | P20062 | |
| VNTVLPEDPEVADLF | 71 | Q8N961 | |
| VVAIDPNVPEDETLI | 36 | A8K7I4 | |
| ATDQTERIVEPPENI | 1081 | A5YKK6 | |
| AELTGVTVELPEEPQ | 301 | Q9UBN6 | |
| EAIIATDPLNPLTAE | 556 | P48736 | |
| QSAELLEEEAPDIPL | 1936 | Q96JI7 | |
| VVQAPSARPEESELL | 456 | Q5JTD0 | |
| ADLEVSLVPPLEDQS | 111 | A6NLX4 | |
| VLEPSLIITAAVPED | 671 | P10074 | |
| ALLEQPVSIPDDDLV | 1116 | Q99973 | |
| QTISEDTDNDLVPPL | 721 | Q4G0A6 | |
| TEILIPEALPATLQD | 726 | Q6ZVD8 | |
| QDEIPSSLILEGVEP | 216 | O60673 | |
| APAPLVSIEELENQE | 11 | Q9Y572 | |
| STIEPREDLLSPVQD | 836 | O94991 | |
| EEPIVSTDEVIFPLT | 141 | Q8WVR3 | |
| SSADVALVELEAPVP | 121 | Q9BQR3 | |
| EEPEQPLTENSLLEV | 736 | Q5XPI4 | |
| LQEVVDDEVLGPSAP | 31 | A0A494C0Z2 | |
| LQEVVDDEVLGPSAP | 31 | P0DUD3 | |
| LQEVVDDEVLGPSAP | 31 | P0DUD4 | |
| LQEVVDDEVLGPSAP | 41 | P0DV79 | |
| LQEVVDDEVLGPSAP | 41 | A0A494C086 | |
| LQEVVDDEVLGPSAP | 41 | A6NIY4 | |
| LAAPQQEALPDETEV | 16 | P09486 | |
| FESVEAAVLLPEEPV | 236 | Q12788 | |
| LSTPPAAALDLQEVE | 411 | Q96RF0 | |
| LVPESQISPVGEELV | 421 | Q9BX26 | |
| AIEAPVDADLVSTVP | 311 | Q06203 | |
| LDSQVPVFEEAPVEL | 26 | A0A0B4J262 | |
| PIEEISVLSPEDLEA | 1051 | Q9NTJ3 | |
| VADDIIQPAAPADLE | 1861 | O95359 | |
| ARLESQEEETIPAAP | 26 | Q9Y2I9 | |
| EAQAVPATLPELEAT | 1251 | Q15149 | |
| LILSPPGTIVSQEED | 781 | A8K0R7 | |
| ETQLLLEVPPSTEDA | 201 | Q9Y5U5 | |
| QELDETLNDEVGTPP | 856 | Q07157 | |
| ERNETIPDIPVSVDN | 206 | Q8TCN5 | |
| VSETEEVALQPLLTP | 646 | Q9C0B5 | |
| PPLAASVEQTLDVRE | 986 | Q9NS56 | |
| LTDPQTAVIEENPLV | 351 | Q9Y2H8 | |
| EATVIEALQAPPDVT | 251 | Q92956 | |
| EALQAPPDVTTVAVE | 256 | Q92956 | |
| QELAEELSTALPAPV | 196 | Q8WUA4 | |
| IPESINVPLDEVGEA | 61 | H0UI37 | |
| PSEEEIVQPLDSTRV | 951 | Q5VWN6 | |
| NEPISPIGLEEDTII | 1941 | Q9BXT5 | |
| INPETDVSLVPDASV | 2496 | Q9BXT5 | |
| PSVEPEIAELSLFAV | 21 | Q9BQ50 | |
| PNVDPVSSLEEDVIR | 11 | Q6PP77 | |
| IPGLDDVTVEVSPLN | 76 | Q9Y3C0 | |
| PESVLQRDDPVLETS | 31 | O95125 | |
| TPPASIEVDENIELI | 351 | P40818 | |
| SSAIEALRLPEQPVD | 331 | P18583 | |
| VPEDPSTLVTVDEIQ | 1726 | Q14966 | |
| SREVIDLDPPAETSQ | 6 | Q9Y2L8 | |
| ERLDLDLTADSQPPV | 491 | Q13263 | |
| EPVAPTEQVITLEET | 1181 | Q9NUA8 | |
| ETVDRLVLESPAPVE | 286 | Q9BWF2 | |
| PLESVVINEDIPVSG | 336 | Q7Z570 | |
| LEETRIATEEPTFIP | 556 | P82987 | |
| SVAELLEPPLESTQI | 341 | Q92539 | |
| SENIPIVITTEPTDD | 241 | Q9NPC6 | |
| LAATQESVPTLLPEE | 201 | P28698 | |
| LEEAPFVIVESVDPL | 411 | Q13224 |